|

EB103 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Estrella Biopharma, Inc.1

Indications

  • CNS Lymphoma1
  • HIV Associated Lymphoma1
  • Lymphoma, Non-Hodgkins1
  • B-Cell Non-Hodgkin's Lymphoma (NHL)1
  • Lymphoma, Non-Hodgkin's, Adult1

Sacramento, California1 trial

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

University of California, Davis

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.